Equity capital markets

Our highly rated equity capital markets team acts for a range of corporate clients and investment banks.

Our highly rated equity capital markets team acts for a range of corporate clients and investment banks. Our corporate clients range from smaller AIM-listed companies to FTSE 100 blue chips. 

While we work with clients across industry sectors, our equity capital markets team has particular expertise in the energy and natural resources (clean energy, oil and gas and mining), funds and financial services, pharma and life sciences, and technology sectors.

Parsley Box

Acted for Parsley Box, a meal delivery business focused on the ‘baby boomer+’ market, on its IPO on London’s Alternative Investment Market (AIM).


Acted for IndigoVision Group plc, the AIM-listed video security surveillance company, in its recommended takeover by Motorola Solutions.

Collagen Solutions

Acted for Collagen Solutions plc, the Glasgow-based life sciences firm, in its takeover by US group Rosen’s Diversified, Inc.

Nucleus Financial

Acted for Nucleus Financial Group plc on its AIM IPO.

Bigblu Broadband plc

Acted for Bigblu Broadband plc on a significant placing to finance two acquisitions and working capital.

Canaccord Genuity Limited

Acted for Canaccord Genuity Limited on a share placing, subscription and open offer by Safestay plc.

Cairn Energy

Acted for Cairn Energy on the $6.3 billion IPO of Cairn India.


Acted for ProStrakan on its main market IPO and subsequent recommended £292 million takeover by Kyowa Kirin.

European Assets Trust

Acted on the IPO of the European Assets Trust and cross-border merger with European Assets Trust NV.

F&C Asset Management

Acted as Scots counsel on the recommended takeover of F&C Asset Management by the Bank of Montreal.

Wolfson Microelectronics

Acted for Wolfson Microelectronics on its £291 million recommended takeover by Cirrus Logic.

Numis Securities

Acted for Numis Securities on the AIM IPO of MyCelx Technologies Corporation.